Wednesday, November 16, 2022
Print Current Day:
|
|
SESSION 23 SCHEDULE | |
Wednesday
SESSION 23:
GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
|
|
x | |
6:40 AM - 6:45 AM | How Do Prior Endovascular Interventions Affect Future Lower Extremity Bypass Outcomes For CLTI |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:46 AM - 6:51 AM | Do Diabetic Patients With CLTI And Substantial Foot Necrosis Have Time For An Endovascular First Strategy: Why Primary Open Bypass Treatment Is Better |
Presenter(s):Katariina M. Noronen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:52 AM - 6:57 AM | Presenting Symptoms Of Lower Extremity Occlusive Disease And Intermittent Claudication In Women: How Do They Differ From Those In Men |
Presenter(s):Linda M. Harris, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:58 AM - 7:03 AM | Selective Coronary Revascularization Based On Preop CT Fractional Flow Reserve (FFRct) Improves 3-Year Survival Of CLTI Patients After Revascularization: Are Current Cardiac Evaluation Guidelines Out Of Date |
Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:04 AM - 7:09 AM | Small Artery Disease (SAD), Medial Artery Calcification (MAC) And Below The Ankle (BTA) Disease: Major Causes Of CLTI With A Poor Prognosis: How Are They Best Treated Endovascularly |
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS | |
7:10 AM - 7:15 AM | [SS] Optimal Different Techniques Of Vessel Prep For Plain Old Balloon Angioplasty (POBA), Drug Coated Balloon (DCB) Treatment And Drug Eluting Stent (DES) Treatment |
Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:15 AM - 7:20 AM | [SS] Technical Tips For Vessel Prep Before DCBs And DESs: It Is Different And Not Simple |
Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:20 AM - 7:25 AM | Tips And What Is New For Safe Radial Access For Renal/Visceral And Lower Extremity Interventions: How Far Distally In The Leg Can Lesions Be Treated |
Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:26 AM - 7:31 AM | What Are The Downsides To Trans-Radial Or Pedal Access |
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE | |
7:32 AM - 7:37 AM | [SS] Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion And Getting A Resistant Balloon To Go Over The Wire |
Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:37 AM - 7:42 AM | [SS] Guidewire Tips For Treating BTK And Crural Artery Lesions |
Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:42 AM - 7:47 AM | [SS] Guidewire Tips For Treating Lesions Below The Ankle (BTA): Sliding, Piercing, Dissecting, Retrograde Maneuvers |
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:47 AM - 7:53 AM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) [ALL TALKS ARE 5 MINUTES]
|
|
x | |
PROGRESS IN ATHERECTOMY | |
7:53 AM - 7:58 AM | New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty |
Presenter(s):George L. Adams, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:59 AM - 8:04 AM | Index Atherectomy Interventions For Intermittent Claudication Are Associated With Higher Reintervention Rates Than Other Endovascular Treatments: Is This Device Specific |
Presenter(s):Caitlin W. Hicks, MD, MS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:05 AM - 8:10 AM | Update On Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial |
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:11 AM - 8:16 AM | Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeon’s View |
Presenter(s):James F. McKinsey, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
UPDATE ON THE SUPERA STENT | |
8:17 AM - 8:22 AM Power Point Presentation with Synched Audio |
Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First |
Presenter(s):Peter C.J. Goverde, MD Location: Grand Ballroom East, 3rd Floor |
|
8:23 AM - 8:28 AM | The Supera Interwoven Stent: When Is It The Best Treatment And How To Optimally Deploy This Unique Stent |
Presenter(s):D. Christopher Metzger, MD / Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
DRUG ELUTING STENTS (DESs) FOR BTK LESIONS | |
8:29 AM - 8:34 AM | Updated 10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations |
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:35 AM - 8:40 AM | Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5-7 Years: From The DISAPEAR Registry And A Meta-Analysis Of The Absorb Stent From Abbott |
Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:41 AM - 8:46 AM | An Update Of Long-Term Outcomes For Drug-Eluting Resorbable Scaffolds Below-The-Knee (BTK) And Progress Of The LIFE-BTK Trial With The Esprit Stent From Abbott |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:47 AM - 8:52 AM | Update On A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND And HEAL Trials |
Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:53 AM - 9:00 AM | Panel Discussion |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY: DEB AND DES ALTERNATIVES TO PACLITAXEL AND RELATED ISSUES
|
|
x | |
9:00 AM - 9:05 AM | Older And More Recent Meta-Analyses Still Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: The More Recent Study Of DCBs In BTK Arteries Showed Increased Mortality And Amputation Rates After Only 1 Year |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:06 AM - 9:11 AM | An Update Of The Real-World Evidence Evaluating Paclitaxel Coated Device Safety In Treating Fempop And Crural Artery Lesions: The SAFE-PAD Study |
Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:12 AM - 9:17 AM | The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data: Let’s Put 4 Years Of Frenetic Activity Into Perspective |
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:18 AM - 9:23 AM Power Point Presentation with Synched Audio |
Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices |
Presenter(s):Christian A. Behrendt, MD Location: Grand Ballroom East, 3rd Floor |
|
9:24 AM - 9:29 AM | The SWING Study: First In Human Use Of A Sirolimus DCB In Arteries Below-The-Knee |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Andrew Holden, MBChB / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:30 AM - 9:35 AM | Alternatives To Paclitaxel Coated Devices For Limiting Intimal Hyperplasia After Treatment: Sirolimus Coating, Bioresorbables And Adventitial Drug Delivery With The Bullfrog Device: How Do Paclitaxel And Limus Drugs Work And How Do They Differ |
Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:36 AM - 9:41 AM | Progress And Problems With A Sustained Release Limus DCB: 3-Year Results With The Magic Touch DCB: From The SIRONA Study |
Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:42 AM - 9:47 AM Power Point Presentation with Synched Audio |
The Light And Darkness Of Fluoropolymer-Based Limus DESs In The Treatment Of Femoropopliteal Lesions |
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
9:48 AM - 9:53 AM | Key New Developments In Endovascular Treatments For CLTI |
Presenter(s):Sahil A. Parikh, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:54 AM - 9:59 AM | Are DESs Ever Associated With Aneurysmal Degeneration: Is It Related To The Drug (Paclitaxel Or Limus) Or To The Fluoropolymer Excipient To Which The Drug Is Attached) |
Presenter(s):Theodosios Bisdas, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:00 AM - 10:08 AM | Panel Discussion |
10:08 AM - 10:18 AM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
|
|
x | |
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs | |
10:18 AM - 10:23 AM | Cost Effectiveness Analysis Of Drug Eluting Technologies For Femoropopliteal Lesions Show That They Are Worth The Increased Device Costs |
Presenter(s):Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:24 AM - 10:29 AM | Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs: There Was No Paclitaxel Mortality Signal |
Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:30 AM - 10:35 AM | Pooled Data From The In.Pact RCT And Real World DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Will The Advantage Of DCBs Diminish With Time |
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:36 AM - 10:41 AM | New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions |
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:42 AM - 10:47 AM | Value Of In.Pact DCBs For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry: What Is The Best Endo Treatment For These Lesions |
Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:48 AM - 10:53 AM | Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages |
Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:54 AM - 10:59 AM Power Point Presentation with Synched Audio |
Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA: How Does It Help Us Determine The Best Treatment For Long Complex ATK Lesions |
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
11:00 AM - 11:05 AM | New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment |
Presenter(s):Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor |
|
11:06 AM - 11:11 AM | 2-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Zilver PTX DES (Cook) With The Eluvia DES (Boston Scientific): Both Are Safe And Effective: Is There A Difference |
Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:12 AM - 11:18 AM | Panel Discussion |
NEW INFORMATION ON BTK DCBs AND DESs | |
11:18 AM - 11:23 AM | Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And New Challenges With Treating CLTI Patients |
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:24 AM - 11:29 AM | The Sirolimus DCB BTK Era Begins – Current Experience With The Selution DEB And Design Of The SELUTION SLR .014 BTK IDE Trial: Early Results From Singapore And Europe |
Presenter(s):Patrick J. Geraghty, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:30 AM - 11:35 AM | Orbital Vessel Preparation To Maximize DCB Efficacy In Calcified BTK Lesions: OPTIMIZE BTK RCT 1-Year Results |
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:36 AM - 11:41 AM Power Point Presentation with Synched Audio |
3-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA |
Presenter(s):Wei Guo, MD / Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:42 AM - 11:47 AM | Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter |
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
11:48 AM - 11:53 AM | Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions |
Presenter(s):Miguel F. Montero, MD / Jihad A. Mustapha, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
Location: Grand Ballroom East, 3rd Floor
Moderators:Joseph L. Mills, MD / Marco G. Manzi, MD / Hasan H. Dosluoglu, MD |
|
x | |
1:00 PM - 1:05 PM | No Option CLTI: What Is It: What Are The Actual Options For Treatment |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:06 PM - 1:11 PM | Contemporary Survival After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: It Is Definitely Worthwhile Saving Limbs Especially In Vascular Patients |
Presenter(s):Philip P. Goodney, MD, MS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES | |
1:12 PM - 1:17 PM | Value Of Spliced Vein Grafts Versus PTFE Grafts For Bypasses When A Single Autologous Vein Is Inadequate |
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | PTFE Tibial And Peroneal Artery Bypasses Can Save No Option Limbs Which Would Otherwise Require Amputation: They Have Worthwhile Long-Term Patency Rates And Limb Salvage Rates |
Presenter(s):Hasan H. Dosluoglu, MD / Gregg S. Landis, MD / Richard F. Neville, MD / Enrico Ascher, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | PTFE Tibial And Peroneal Bypasses: Cases With Ultra-Long-Term Patency And Limb Salvage Prove Their Value When There Are No Other Options: Why Do They Work For Some Surgeons But Not Others |
Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Hasan H. Dosluoglu, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option That Yields Acceptable Mid-Term Patency And Long-Term Limb Salvage Rates |
Presenter(s):R. Clement Darling III, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:36 PM - 1:41 PM | Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Is There Variability Between Surgeons And Institutions |
Presenter(s):Matthew T. Menard, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI | |
1:42 PM - 1:47 PM | Role And Value Of Vein Arterialization: Best Way To Do It And Long-Term Results: From The Pioneer |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:48 PM - 1:53 PM | Pathophysiology Of Venous Arterialization And Neo Angiogenesis For No Option CLTI: How To Predict When It Will Work And When It Won’t: What Is The Medial Arterial Calcification (MAC) Score And Its Significance |
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:54 PM - 1:59 PM | Pivotal US Trial (PROMISE II), US Feasibility Study (PROMISE I) And European 2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing |
Presenter(s):Daniel G. Clair, MD / Andrej Schmidt, MD / Daniela Branzan, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:00 PM - 2:05 PM | How To Perform The LimFlow Procedure: Equipment Required And Technical Tips |
Presenter(s):Miguel F. Montero, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:06 PM - 2:11 PM | Deep Vein Arterialization And Valve Lysis By Surgical Means For No Option Desert Feet With Gangrene: How To Do It And Results |
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:12 PM - 2:18 PM | Panel Discussion |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
|
|
x | |
2:18 PM - 2:23 PM | Why The BioMimics 3D Stent Should Be The Treatment Of Choice In Complex Patients And Lesions |
Presenter(s):Peter Gaines, MD / Michael K.W. Lichtenberg, MD / Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
ARTERIAL PTFE BYPASSES | |
2:24 PM - 2:29 PM | RCT Comparing Heparin Bonded PTFE (Propaten) Grafts With Plain PTFE Grafts For BTK CLTI Bypasses: Is Heparin Bonding Helpful |
Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:30 PM - 2:35 PM | Hybrid Fluoroscopically Guided Improved Method For Restoring Patency To Occluded PTFE Bypasses: It’s Less Invasive And More Effective |
Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
PERCUTANEOUS BYPASSES | |
2:36 PM - 2:41 PM | Percutaneous (PQ) Transvenous Fempop PTFE Bypasses With The Torus 2 Device (Now From Endologix): How It Works And Status Of The DETOUR And TORUS Trials In The US: 1-Year Results |
Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:42 PM - 2:47 PM | 4-Year Results Of The Detour PQ Fempop Arterial Bypass Routed Through The Femoral Vein: Will It Make Open Bypass Obsolete |
Presenter(s):Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:48 PM - 2:53 PM | A Novel Technique For Percutaneous Extravascular Fempop Bypass - Routing A PTFE Graft Through The Soft Tissue Of The Thigh: It Is A Transcatheter Technique That Is Clampless, Sutureless And Without External Exposure: How Does It Work And Results |
Presenter(s):Pierre G. Sarradon, MD, MDC / Jean Pierre Becquemin, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:54 PM - 2:58 PM | Panel Discussion |
NEW INFORMATION ON STENT-GRAFTS | |
2:58 PM - 3:03 PM | Can Viabahn Stent-Grafts Be Used Safely And Effectively In The SFA For CLTI: From Pooled Multicenter Data: What Are The Limitations Of These Devices |
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:04 PM - 3:09 PM | How Can IVUS Improve Outcomes When Self-Expanding Stent-Grafts (Viabahn) Are Used To Treat SFA Occlusive Lesions |
Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:10 PM - 3:15 PM | Advantages, Limitations And Results Of Gore VBX BE Stent-Graft For Occlusive Disease In Various Vascular Beds And For F/B/EVAR Branches |
Presenter(s):Rocco Giudice, MD / Ciro Ferrer, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
TREATMENT OF IN STENT RESTENOSIS (ISR) | |
3:16 PM - 3:21 PM | Laser Atherectomy May Facilitate Endovascular Treatment Of ISR But Does Not Provide Long-Term Benefit: How Should ISR Be Treated |
Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:22 PM - 3:27 PM | The Excimer Laser For Treating ISR: It Has A Role In Crossing And Debulking Difficult Lesions: Technical Tips |
Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:28 PM - 3:33 PM | How Best To Treat Long Difficult Complex SFA Lesions Including Those From ISR |
Presenter(s):Sonia Ronchey, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:34 PM - 3:46 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
Location: Grand Ballroom East, 3rd Floor
Moderators:Mark K. Eskandari, MD / Jacques Busquet, MD / Frank J. Veith, MD |
|
x | |
3:46 PM - 3:51 PM | The Japanese SPINACH Registry Shows Why WIfI Wound Severity Helps To Select Open Versus Endovascular Treatment And Predicts Patient Survival |
Presenter(s):Nobuyoshi Azuma, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:52 PM - 3:57 PM | The New Global Vascular Guidelines And WIfI Staging For CLTI Are Better Than Obsolete TASC Guidelines Because Treatment Recommendations, Revascularization Strategies And Needs For The Future Are Not Based On Lesion Anatomy But Are Nuanced By Other Factors: What Are They |
Presenter(s):Michael S. Conte, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:58 PM - 4:03 PM | The Main Outcomes Of The BEST-CLI RCT Comparing Endovascular And Open Treatment Of Lower Extremity Ischemia: Limitations And What Will Be Its Value |
Presenter(s):Alik Farber, MD, MBA / Matthew T. Menard, MD / Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:04 PM - 4:13 PM | Panel Discussion On Meaning And Significance Of Best-CLI Results |
Panelist(s): Marianne Brodmann, MD / Michael S. Conte, MD / Matthew T. Menard, MD / Kenneth Rosenfield, MD | |
METHODS FOR EVALUATING FOOT PERFUSION | |
4:13 PM - 4:18 PM | Value Of Perfusion Assessment Of The CLTI Foot Before Treatment And For Quality Control After Revascularization: How Best To Do It |
Presenter(s):Maarit Venermo, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:19 PM - 4:24 PM Power Point Presentation with Synched Audio |
How And Why To Measure Foot Perfusion During Endo Treatments: Hyperspectral Imaging, O2 Sensors, etc: When Is The Angiosome Concept Helpful; When Not |
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
4:25 PM - 4:30 PM | New Methods For Evaluating Lower Extremity Arterial Lesions And Foot Perfusion Using Fractional Flow (FFR) And MRI; How They Work And Their Value In Assessing Therapeutic Success |
Presenter(s):Bijan Modarai, PhD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:31 PM - 4:36 PM | Pedal Arch Patency Is Key To Predicting Limb Salvage With Endovascular Treatment For CLTI With Tissue Necrosis: How Is It Best Evaluated |
Presenter(s):Hasan H. Dosluoglu, MD / Linda M. Harris, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:37 PM - 4:42 PM | Foot Perfusion Measurements Are Invaluable In CLTI And Predicting Amputation Healing: They Also Show Why Open Bypasses Are Often Better Than Endovascular Treatments |
Presenter(s):Werner Lang, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:43 PM - 4:48 PM | Panel Discussion |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA
|
|
x | |
INTERMITTENT CLAUDICATION (IC) | |
4:48 PM - 4:53 PM | DEBATE: A RCT After 2 Years Shows That Stent Treatment For Intermittent Claudication (IC) Improves Quality Of Life More Than Medical Treatment And Exercise And Is Cost Effective |
Presenter(s):Hans Lindgren, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:54 PM - 4:59 PM | DEBATE: Interventions For IC Are Safe But Lead To Greater Decreased Function And Increased Limb Loss |
Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:00 PM - 5:05 PM | Overuse Of Vascular Interventions For IC Is A Measure Of Poor Care: How Is This Determined |
Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:06 PM - 5:11 PM | Endovascular Interventions For IC: At 2 Years Only 32% Are Free From IC Recurrence: What Factors Decrease This Recurrence Rate: From A VQI Study |
Presenter(s):Karen Woo, MD, PhD / Peter F. Lawrence, MD / Michael S. Conte, MD / Adam Beck, MD / Marc L. Schermerhorn, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:12 PM - 5:16 PM | Panel Discussion |
ACUTE LIMB ISCHEMIA (ALI) (See Also Session 63) | |
5:16 PM - 5:21 PM | Key Points From The 2020 New European Guidelines For Diagnosis And Treatment Of ALI In The Upper And Lower Limbs: When To Use Which Treatments: How Have These Guidelines Been Modified Recently |
Presenter(s):Martin Bjorck, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:22 PM - 5:27 PM | Update On Thrombosuction Devices For Treating ALI: Which Device In Which Circumstance: Advantages And Limitations |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:28 PM - 5:33 PM | Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best – When And Why |
Presenter(s):Patrick E. Muck, MD, FACS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:34 PM - 5:39 PM | Percutaneous Vacuum Thrombectomy For ALI: Devices And Techniques: In 2022 What Is The Residual Role For Thrombolytics And Open Balloon Catheter Thrombectomy |
Presenter(s):Scott L. Stevens, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:40 PM - 5:45 PM | Penumbra Indigo Clot Aspiration System: What Makes It Different: Indications And Contraindications: What Is New In 2022 |
Presenter(s):James F. Benenati, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:46 PM - 5:51 PM | Value And Technical Tips For Using The Indigo Clot Removal System Before And After Treating ISR And Other Lesions With Balloon And Stents |
Presenter(s):Frank R. Arko, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:52 PM - 5:57 PM | How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:58 PM - 6:02 PM | Panel Discussion |
6:02 PM - 6:02 PM | End of Program D |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
|
|
x | |
6:46 AM - 6:51 AM Power Point Presentation with Synched Audio |
New Information From The VOYAGER And COMPASS Trials With Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin: How Does It Help In The Management Of Patients With Arterial And Venous Disease: With And Without Kidney Disease And With And Without Statins |
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom West, 3rd Floor |
|
6:52 AM - 6:57 AM | New Strategies On How To Avoid And Treat Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients |
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
6:58 AM - 7:03 AM Power Point Presentation with Synched Audio |
Update On LDL-C Lowering During A Lifetime: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins |
Presenter(s):J. David Spence, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:04 AM - 7:09 AM | DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful: What Does The Latest Evidence Show |
Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:10 AM - 7:15 AM | DEBATE: Not So: Update On LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death |
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:16 AM - 7:21 AM | Low Dose Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo And Open Treatments For PAD/CLTI: From The VOYAGER RCT: What Does The XATOA Prospective Registry Add |
Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:22 AM - 7:27 AM Power Point Presentation with Synched Audio |
How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:28 AM - 7:33 AM | New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For |
Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:34 AM - 7:42 AM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19
|
|
x | |
UPDATE ON RENAL DENERVATION FOR HYPERTENSION | |
7:42 AM - 7:47 AM | Current Status Of Renal Denervation For Drug Resistant Hypertension: Why The Simplicity Spyral Radiofrequency Denervation System Is Different: Status Of The SPYRAL HTN-OFF MED RCT (Versus Sham) |
Presenter(s):Sahil A. Parikh, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:48 AM - 7:53 AM | Updates On Other Methods Of Renal Denervation: Chemical (Alcohol) Infusion Via The Peregrine Catheter (Ablative Solutions) And Ultrasound Via The Paradise Catheter (ReCor Medical) |
Presenter(s):Horst Sievert, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:54 AM - 7:59 AM | Update On The Status Of Renal Denervation For Hypertension: Is It Here To Stay: Where Is It Going |
Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT | |
8:00 AM - 8:05 AM | How Does the Female Sex Impact The Occurrence Of Lower Extremity Atherosclerosis, Its Treatment And Results Of Treatment |
Presenter(s):Katherine A. Gallagher, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:06 AM - 8:11 AM Power Point Presentation with Synched Audio |
How And Why Do Thoracic Stent-Grafts For TEVAR Negatively Affect The Heart |
Presenter(s):Frans L. Moll, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:12 AM - 8:17 AM | When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks Because Duration Of Cessation Matters |
Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:18 AM - 8:23 AM | Limiting Transfusion And Permitting Anemia After Major Vascular Operations Increases Mortality And Serious Adverse Events Especially In Patients With Cardiac Co-Morbidities |
Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:24 AM - 8:29 AM | How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why It’s Important In Decision Making And What To Do About It Other Than Treating ACS Patients Non-Invasively |
Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:30 AM - 8:35 AM | Update On Vascular Complications Of COVID-19 Infections: What Is Known And Unknown: How To Diagnose And Treat: Endo Versus Open |
Presenter(s):Michael E. Barfield, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:36 AM - 8:41 AM | Update On Cardiac Complications Of COVID-19 Infections: What Is Their Genesis: Diagnosis And Treatment |
Presenter(s):Roxana Mehran, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:42 AM - 8:50 AM | Panel Discussion |
8:50 AM - 9:06 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
|
|
x | |
TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS | |
9:06 AM - 9:11 AM | Most Type 2 Endoleaks Are Benign: The Case Can Be Made That By Treating Type 2 Endoleaks The Harm And Cost Of Such Treatment Outweighs The Benefits: When If Ever Should They Be Treated: Is There A Relationship With AAA Remodeling |
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
TREATING TYPE 1 ENDOLEAKS | |
9:12 AM - 9:17 AM | Type 1A Endoleaks After EVAR: Predictability Does Not Equate To Preventability: How Are They Best Treated |
Presenter(s):Michael J. Singh, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:18 AM - 9:23 AM | When And How To Treat Type 1 Endoleaks With Embolization: Technical Tips |
Presenter(s):Robert A. Morgan, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:24 AM - 9:29 AM | When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately |
Presenter(s):Sigrid Nikol, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:30 AM - 9:35 AM | How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): A Standard Protocol Helps |
Presenter(s):David J. Minion, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:36 AM - 9:41 AM Power Point Presentation with Synched Audio |
Fibrin Glue Sac Filling Technique During EVAR To Prevent All Endoleaks: It Should Be Routine And Is A Game Changer Based On A Multicenter Trial: How To Do It |
Presenter(s):Qingsheng Lu, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:42 AM - 9:48 AM | Panel Discussion |
PREVENTION OF TYPE 2 ENDOLEAKS AFTER EVAR | |
9:49 AM - 9:54 AM | A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: The Next Generation Of EVAR Endografts Must Prevent Endoleaks: How Can It Be Done |
Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:55 AM - 10:00 AM | Preventing Threatening Type 2 Endoleaks By IMA Embolization When AAA Sac And IMA Are Large: Indications And Technical Tips And Evidence |
Presenter(s):Toru Kuratani, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:01 AM - 10:06 AM | With A Large IMA (>3 mm), When Should It Be Embolized; When Should It Be Revascularized And Why |
Presenter(s):Piotr M. Kasprzak, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:07 AM - 10:12 AM | Selective Coiling Of IMA And Lumbar Arteries Decrease Harmful Type 2 Endoleaks After EVAR: When And How To Do It |
Presenter(s):Götz M. Richter, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:13 AM - 10:19 AM | Panel Discussion |
TREATMENT OF TYPE 2 ENDOLEAKS AND ENDOTENSION AFTER EVAR | |
10:20 AM - 10:25 AM | How Duplex Ultrasound Velocities In Type 2 Endoleaks Determine Behavior And Help In Treatment: Technical Tips |
Presenter(s):Ross Milner, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:26 AM - 10:31 AM | Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It |
Presenter(s):Neal S. Cayne, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:32 AM - 10:37 AM | New Concepts In Post EVAR Endoleaks And Endotension: The Role Of Fabric Fatigue, Concealed Endoleaks And AAA Sac Hygromas: How Can These Be Detected And Best Treated |
Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:38 AM - 10:43 AM | How To Best Leverage 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Value Of Transcaval Access For Type 1 And 2 Endoleaks |
Presenter(s):Mark W. Mewissen, MD, RVT Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:44 AM - 10:49 AM | Transgraft Approach To Treat Type 2 Endoleaks: Indications, Equipment, Advantages And Precautions |
Presenter(s):James F. McKinsey, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:50 AM - 10:55 AM | Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique |
Presenter(s):Zvonimir Krajcer, MD, FACC Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:56 AM - 11:01 AM | With Type 2 Endoleaks And Sac Expansion Open Sacotomy And Branch Ligation Is The Best Treatment: Why And What Precautions Are Needed To Be Sure There Is No Occult Type 1 Leak |
Presenter(s):Zachary M. Arthurs, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:02 AM - 11:11 AM | Panel Discussion |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
TCT AND PLINIO ROSSI RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES
Location: Grand Ballroom West, 3rd Floor
Moderators:TBD |
|
x | |
TCT RECORDED LIVE CHALLENGING ENDOVASCULAR CASES | |
Moderator(s): Juan F. Granada, MD / Sahil A. Parikh, MD | |
11:12 AM - 11:36 AM | PROGRAM TO BE DETERMINED |
PLINIO ROSSI’S RECORDED LIVE COMPLEX AND CHALLENGING ENDO CASES | |
Moderator(s): Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD | |
11:36 AM - 11:48 AM | Reconstruction Of Symptomatic And Chronically Occluded Iliac Veins And IVC (Video Presentation And Discussion) |
Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
11:48 AM - 12:00 PM | A Complex Below-The-Knee Occlusive Case And Management Of Multiple Complications (Video Presentation And Discussion) |
Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE LINC GROUP
Location: Grand Ballroom West, 3rd Floor
Moderators:Dierk Scheinert, MD / Andrej Schmidt, MD / Daniela Branzan, MD |
|
x | |
1:00 PM - 1:32 PM | PROGRAM TO BE DETERMINED |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
ISSUES IMPORTANT IN VASCULAR SURGERY: LEADERSHIP, HISTORY, EFFICIENCY, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
|
|
x | |
1:33 PM - 1:38 PM | How To Succeed In Academic Vascular Surgery: Don’t Be A Revolutionary |
Presenter(s):Ronald L. Dalman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:39 PM - 1:44 PM | Surgeons In The Time Of Pandemics: How Does Our Current COVID Crisis For Surgeons Compare To The Plague And Guy de Chauliac In 14th Century France |
Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:45 PM - 1:50 PM | How To Improve Operating Room Efficiency For Vascular Surgical Operations: Why Is Inefficiency In This Setting So Widespread And Hard To Fix |
Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:51 PM - 1:56 PM | Patient Reported Outcomes (PROs): What Are They: Importance And Pitfalls: How Do They Differ From Patient Satisfaction |
Presenter(s):Christopher J. Smolock, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:57 PM - 2:02 PM | In A Malpractice Proceeding Or Trial What Recourse Does A Physician-Defendant Have When An Expert Witness Provides Inaccurate Or False Testimony |
Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:03 PM - 2:08 PM | RCTs And Meta-Analyses Can Be Flawed And Biased: They Should Only Be Viewed With Other Evidence And Common Sense |
Presenter(s):George S. Lavenson, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:09 PM - 2:14 PM | Why Systematic Reviews And Meta-Analyses Can Be Misleading: What To Do About It |
Presenter(s):Janet T. Powell, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
ISSUES IN VASCULAR TRAINING | |
2:15 PM - 2:20 PM | Optimal New Training Paradigm For Vascular Surgeons: 0+5 Vascular Surgery Residency Followed By 2 Years Of Cardiac Surgery Residency Training: Why Is It Better Than 2 Extra Years Of Laboratory Research |
Presenter(s):Alan B. Lumsden, MD, FACS |
|
View Slides in PDF | |
2:21 PM - 2:26 PM | Coming Crisis In Vascular Surgical Training – In Both 5+2 And 0+5 Programs: What Can Be Done About It |
Presenter(s):Michael B. Silva, Jr., MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:27 PM - 2:32 PM | How To Remedy The Deficiency Vascular Fellows And Residents Have In Their Numbers Of Open Vascular Surgical Operations |
Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:33 PM - 2:38 PM | Negative Impact Of The COVID Pandemic On Vascular Surgical Training: How Long Will They Last |
Presenter(s):Jason T. Lee, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:39 PM - 2:44 PM | How Human Behavior Is Controlled By Biases And Rationalizations: How To Overcome These And Perform Better |
Presenter(s):Scott L. Stevens, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:45 PM - 2:58 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
|
|
x | |
2:58 PM - 3:03 PM | The Wellness Of Vascular Surgeons: Physical And Mental: How To Monitor And Promote It: The Importance Of Intraoperative Posture |
Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:04 PM - 3:09 PM | Unfilled Promises With Devices, Drugs And Treatments: Initial Hype That Is Not Fulfilled: It Is Often Hidden: More Transparency Is Needed: A Few Examples |
Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:10 PM - 3:15 PM | Heart And Vascular Centers Are Artificial Entities That Disadvantage Vascular Surgeons |
Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:16 PM - 3:21 PM Power Point Presentation with Synched Audio |
Effect Of Increased Hydration And Protein Intake On Lower Extremity Arteriosclerotic Ischemia With IC And CLTI: What Is The Evidence And The Mechanism: Will It Change The Game And Decrease The Need For Stents And Bypasses |
Presenter(s):Juan C. Parodi, MD / Samuel Fernandez, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:22 PM - 3:27 PM | Vascular Spinoff Revenue In Tertiary Healthcare Systems: More Downstream Benefits From Vascular Surgeons: How To Make Hospital Administrators Appreciate The Value Of Vascular Surgeons |
Presenter(s):Joseph V. Lombardi, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:28 PM - 3:33 PM | The Ever Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going |
Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:34 PM - 3:39 PM | Panel Discussion |
ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs | |
3:39 PM - 3:44 PM | A Balanced View Of Atherectomy In Ambulatory Surgicenters (ASCs) And OBLs In 2022: Are There Differences And Is The Procedure Overused |
Presenter(s):Krishna Jain, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:45 PM - 3:50 PM | Why And How Do Outpatient Angio Suites And OBLs Fail |
Presenter(s):Sam S. Ahn, MD, FACS, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:51 PM - 3:56 PM | How Can OBLs Provide Good Vascular Care With Excellent Results, Be Profitable And Still Allow Vascular Surgeons To Only Work From 8 AM to 5 PM |
Presenter(s):Mark A. Mattos, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:57 PM - 4:02 PM | Tips And Tricks For Performing High-Risk Lower Extremity Endovascular Procedures Safely And Successfully In An Outpatient Setting |
Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:03 PM - 4:08 PM | OBL Audits: What Are They Looking For And How To Avoid Civil And Criminal Penalties |
Presenter(s):O. William Brown, MD, JD |
|
View Slides in PDF | |
4:09 PM - 4:13 PM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; ETHICS OF FDA ACCESS; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES, ENDPOINTS; INDUSTRY RELATIONS; IMPACT OF GOVERNMENT (ACA) AND REGULATORY AGENCIES (FDA)
|
|
x | |
4:13 PM - 4:18 PM | What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2022: Will Planned Increased Reimbursement For Office And Hospital Visits Cause Decreases In Procedural Reimbursements |
Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:19 PM - 4:24 PM | How Can Vascular Surgeons Identify High Risk, High-Cost Patients And Help Health Care Systems Control Costs: How To Prevent Inappropriate Treatments In These Patients |
Presenter(s):Lee Kirksey, MD Location: Grand Ballroom West, 3rd Floor |
|
4:25 PM - 4:30 PM | International Consortium of Vascular Registries (ICVR) And The Use Of Real World Evidence To Evaluate Aortic Endograft Performance In Ruptured Aneurysms |
Presenter(s):Adam Beck, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:31 PM - 4:36 PM | The Role And Value Of Guidelines In Vascular Practice; Why Guidelines Can Be Misleading; How Should They Be Written To Not Be |
Presenter(s):Anders Wanhainen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:37 PM - 4:42 PM | Non-Compliance With The SVS AAA Practice Guidelines Is Common: How Does It Impact Outcomes |
Presenter(s):Elliot L. Chaikof, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:43 PM - 4:48 PM | Ethics Of Limiting Access To Potentially Promising Technology: At What Point Is It Ethical To Use And Evaluate An Innovative Technology In A Patient/Clinical Study |
Presenter(s):Valerie M. Merkle, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:49 PM - 4:54 PM | Managing Various Specialties And Generations Of Specialists In A Multi-Specialty Vascular Institute Or Center: How To Optimize Patient Outcomes |
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:55 PM - 5:00 PM Power Point Presentation with Synched Audio |
Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Mostly Ethical And Beneficial To Patients And Society: Pitfalls To Avoid |
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:01 PM - 5:06 PM | How Do Surgeons Drive Vascular Innovation: What Are The Critical Steps Leading To Success |
Presenter(s):Jeffrey H. Lawson, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:07 PM - 5:14 PM | Panel Discussion |
EVIDENCE BASED MEDICINE ISSUES | |
Moderator(s): Jack L. Cronenwett, MD / Sean P. Roddy, MD | |
5:14 PM - 5:19 PM | Propensity Score Matching Studies: How Do They Work And What Are Their Strengths And Weaknesses |
Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:20 PM - 5:25 PM | Registry Based RCTs: What Are They And Why Are They Better Than Other Evidence Based Techniques |
Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
REGULATORY ISSUES | |
5:26 PM - 5:31 PM | Historical Perspective Over The Last 25 Years On FDA Approvals Of EVAR Devices Submitted By Investigators And Industry: Lessons Learned To Guide Future Applications |
Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
JOURNAL ISSUES | |
5:32 PM - 5:37 PM | How To Get A Paper Accepted In A High Impact Journal Like The JVS: Does Bias Ever Matter |
Presenter(s):Peter Gloviczki, MD / Peter F. Lawrence, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
SVS, GOVERNMENT AND MEDICAL INSURANCE TOPICS | |
5:38 PM - 5:43 PM | The SVS Foundation: How Does It Serve Vascular Surgeons And Their Patients |
Presenter(s):Peter F. Lawrence, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:44 PM - 5:49 PM | Effects Of The Affordable Care Act (ACA) On Vascular Surgical Outcomes: Does The Medicaid Expansion Of The ACA Improve Outcomes Or Not |
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:50 PM - 5:55 PM | If You Want Medicare For All Look At The NHS First |
Presenter(s):Firas F. Mussa, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:56 PM - 6:05 PM | Panel Discussion |
6:05 PM - 6:05 PM | End of Program E |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), PENETRATING AORTIC ULCERS (PAUs) AND THEIR TREATMENT
Location: Trianon Ballroom, 3rd Floor
Moderators:Ramon Berguer, MD, PhD / Paulo E. Ocke Reis, MD, PhD |
|
x | |
6:50 AM - 6:55 AM | False Lumen Thrombosis Is An Overused And Meaningless Endpoint In The Treatment Of Uncomplicated TBAD |
Presenter(s):Firas F. Mussa, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
6:56 AM - 7:01 AM | Acute Aortic Dissection (Type A And B) Is More Common Than We Think: From A Swedish Population Based Study: Why Are We Missing Cases And What Can Be Done About |
Presenter(s):Johnny Steuer, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:02 AM - 7:07 AM | Value Of Stent-Grafts In Genetically Triggered Aortopathy |
Presenter(s):Cherrie Z. Abraham, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:08 AM - 7:13 AM | What Is Best Medical Treatment For TBAD Patients: How Best To Control Blood Pressure And To Get Patients To Comply: They Don’t |
Presenter(s):Colin D. Bicknell, MD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:14 AM - 7:19 AM | Multimodular Approach To Treating Chronic TBADs With TAAAs: Who Needs A F/B/EVAR; Who Needs A Candy-Plug |
Presenter(s):Tilo Koelbel, MD, PhD / Fiona Rohlffs, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:20 AM - 7:25 AM | Panel Discussion |
7:25 AM - 7:30 AM | Comparison Of The STABILISE And Petticoat Techniques For Treatment Of Acute And Subacute TBADs: Preliminary Results Suggest STABILISE Achieves Better False Lumen Obliteration |
Presenter(s):Igor A. Laskowski, MD, PhD / Josh B. Goldberg, MD / Heepeel Chang, MD |
|
View Slides in PDF | |
7:31 AM - 7:36 AM | Reinterventions After TEVAR For TBADs: How To Plan For The Future At The Index Procedure And Strategies For Successful Repair In The Chronic Phase |
Presenter(s):Bijan Modarai, PhD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:37 AM - 7:42 AM | Requirement For Adjunctive Branch Stents After TEVAR For Complicated TBADs Is An Indicator Of Poor Prognosis: What Can Be Done To Offset It |
Presenter(s):Mark K. Eskandari, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:43 AM - 7:48 AM | Update On Intramural Hematoma (IMH): The Majority Can Be Managed With Medical Treatment And Close Observation, But Some Require Urgent Intervention: Which Ones |
Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:49 AM - 7:54 AM | Natural History And Optimal Treatment For Penetrating Aortic Ulcers (PAUs): When To Observe And When To Treat With TEVAR |
Presenter(s):Colin D. Bicknell, MD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:55 AM - 8:00 AM | Panel Discussion |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
|
|
x | |
8:00 AM - 8:05 AM | The Majority Of TBAD Patients – Complicated And Uncomplicated – Require Secondary Endovascular Procedures After TEVAR: What Secondary Procedures And When |
Presenter(s):Götz M. Richter, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:06 AM - 8:11 AM | Antegrade Stent-Graft Delivery For Treating Acute Type A Dissections: When Is It Advantageous And How To Do It |
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:12 AM - 8:17 AM | Status Of A Catheter Aortic Septotomy Device For Treating Aortic Dissections: Why And How Should It Work As A Treatment |
Presenter(s):Ramon Berguer, MD, PhD / Juan C. Parodi, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:18 AM - 8:23 AM | Caval Balloon Occlusion: A Better Way Than Rapid Pacing To Permit Precise Stent-Graft Placement In The Proximal Aorta: How To Do It And Is It Better For The Heart |
Presenter(s):Nuno V. Dias, MD, PhD / Bjõrn Sonesson, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:24 AM - 8:29 AM | Updated Experience For Precise TEVAR Placement In Or Near The Arch By Valsalva And PEEP: It Is Safe And Effective: Adenosine, Rapid Pacing And Caval Occlusion Are NOT Needed: How To Do It And How To Do It With A Prosthetic Aortic Valve |
Presenter(s):Nikolaos Tsilimparis, MD; PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:30 AM - 8:35 AM | Panel Discussion |
8:35 AM - 8:40 AM Power Point Presentation with Synched Audio |
Arch Lesion Repair With Single, Double Or 3-Branched Devices: When Is Each Best And Why: How To Do It From A Totally Femoral Approach |
Presenter(s):Gustavo S. Oderich, MD FACS Location: Trianon Ballroom, 3rd Floor |
|
8:41 AM - 8:46 AM | Chimney Technique For Dealing With Total Arch Lesions And Dissections: How To Make It Work, Limitations And Results |
Presenter(s):Ivo Petrov, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:47 AM - 8:52 AM | Laser Fenestrations And Total Percutaneous Techniques For Endovascular Arch Repair |
Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:53 AM - 8:59 AM Power Point Presentation with Synched Audio |
In Situ Fenestration With Life Tech Technology For Aortic Arch Aneurysms: An Alternative To Branched Graft Devices And Parallel Grafts: Results In >50 Cases And How Does The New Technology Work |
Presenter(s):Ralf R. Kolvenbach, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:59 AM - 9:04 AM | Multicenter International Study On Preloaded Fenestrated Endografts With A Modified Biport Handle (Cook): A Way To Make F/EVAR Easy: How Does The System Work |
Presenter(s):Nikolaos Tsilimparis, MD; PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:05 AM - 9:11 AM | Panel Discussion |
9:11 AM - 9:24 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
|
|
x | |
COMPLEX AAAs AND TAAAs | |
9:24 AM - 9:29 AM | Lower Extremity Ischemic Complications After F/B/EVAR: Etiology And How To Avoid Them |
Presenter(s):Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:30 AM - 9:35 AM | Long-Term Survival Results After Type II TAAA Endovascular Repair: When Is The Procedure Contraindicated |
Presenter(s):Matthew J. Eagleton, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:36 AM - 9:41 AM | How To Make 3 Chimney EVAR With Involvement Of The SMA Safe And Effective |
Presenter(s):Manish Mehta, MD, MPH Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:42 AM - 9:47 AM | Value Of Ch/EVAR For Juxtarenal AAAs: They Are As Safe And Effective As Any Other Procedure And Simpler: Based On A Meta-Analysis Of Mid-Term Outcomes |
Presenter(s):Joost van Herwaarden, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:48 AM - 9:53 AM | Risk Factors Associated With Long-Term Mortality And Complications After Open And Endovascular TAAA Repair: What Is The Role Of Open Repair In 2022 |
Presenter(s):Thomas F. Lindsay, MDCM, FRCS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:54 AM - 9:59 AM | Comparison Of Endo And Open Repair Of Post Dissection TAAAs: Which Procedure Is Best And When |
Presenter(s):Fabio Verzini, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:00 AM - 10:05 AM | Comparative Morbidity And Mortality Outcomes Of Open, Hybrid And F/B/EVAR For Type II And III TAAAs Justify Greater Use Of F/B/EVAR For These Complex Lesions |
Presenter(s):Gilbert R. Upchurch, MD / Sal Scali, MD / Dean Arnaoutakis, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:06 AM - 10:12 AM | Panel Discussion |
TOPICS RELATED TO INTERESTING NEW DEVICES | |
10:12 AM - 10:17 AM | Update Of A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Clinical Experience And Advantages |
Presenter(s):Sebastian E. Debus, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:18 AM - 10:23 AM | How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur |
Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:24 AM - 10:29 AM | Update On The Role Of Device Engineering And Components On Sac Regression: Failed Regression After EVAR Are Device Related Not Patient Related |
Presenter(s):Michael C. Stoner, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:30 AM - 10:35 AM Power Point Presentation with Synched Audio |
WeFlow Device For Juxtarenal AAA, TAAA And Arch Repairs: A New Inner Branch And Outer Branch Approach: How Does It Work And Early Results |
Presenter(s):Wei Guo, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:36 AM - 10:40 AM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
Location: Trianon Ballroom, 3rd Floor
Moderators:Thomas S. Maldonado, MD / Nicholas J.W. Cheshire, MD |
|
x | |
TREATMENT OF ILIAC ANEURYSMS AND IBDs | |
10:40 AM - 10:45 AM | Surprisingly, Occlusion Of 1 Or Both Hypogastric Arteries During EVAR Does NOT Result In Serious Adverse Events: From A Large VQI Study |
Presenter(s):Heepeel Chang, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:46 AM - 10:51 AM | Update On The Gore IBD Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Advantages And Limitations: From The European ICEBERG Registry |
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:52 AM - 10:57 AM | Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Including After Previous EVAR And In Octogenarians |
Presenter(s):Giovanni B. Torsello, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:58 AM - 11:03 AM | Long-Term Comparison Of The Cook Zenith And Gore Excluder IBDs: Advantages And Limitations Of Both: What Is The Best Bridging Stent |
Presenter(s):Giovanni Pratesi, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:04 AM - 11:09 AM | An Iliac Customized Fenestrated Device (From Terumo Aortic): When And How Can It Work In Anatomies Unsuitable For Branched Endografts: Advantages And Limitations |
Presenter(s):Fadi Taher, MD / Afshin Assadian, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:10 AM - 11:15 AM | Advantages Of The Artivion (Formerly CryoLife/Jotec) IBD Device Now From Artivion For Treating Common And Internal Iliac Artery Aneurysms: When Bell Bottom Technique; When IBD |
Presenter(s):Lee Bouwman, MD, PhD, MSc Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:16 AM - 11:22 AM | Panel Discussion |
11:22 AM - 11:27 AM | Systematic Review And Meta-Analysis Of The Multilayer Flow Modulating Bare Stent (From Cardiatis) For Complex Aortic Lesions: Early And Mid-Term Results Are Still Interesting: Does This Technology Have A Future |
Presenter(s):George Geroulakos, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:28 AM - 11:33 AM | Resurgence Of Interest In Uncovered Bare Stents As A Promising Treatment For Acute Aortic Dissections: What Is Their Future |
Presenter(s):Rodney A. White, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:34 AM - 11:39 AM | Role Of Bare Metal AMDS Stents From Artivion (Formerly CryoLife/Jotec) For Repair Of Acute Type A Dissections: Indications And Results |
Presenter(s):Wilson Y. Szeto, MD / Grayson H. Wheatley, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:40 AM - 11:45 AM | MLFM Bare Stents Will Be Effective Treatment For Aortic Dissections: How Extensive A Portion Of The Aorta Needs To Be Treated |
Presenter(s):Claude D. Vaislic, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:46 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Wednesday
SESSION 43:
MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
|
|
x | |
1:00 PM - 1:05 PM | Update On A Novel New Technology (Nectero) To Slow AAA Growth; How Does It Work And Early Clinical Results |
Presenter(s):Venkatesh G. Ramaiah, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
AAA NECK BEHAVIOR AFTER EVAR | |
1:06 PM - 1:11 PM | Optimal Stent Design And Optimal Degree Of Oversizing To Avoid Neck Dilatation And Why It Matters |
Presenter(s):Carlos F. Bechara, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:12 PM - 1:17 PM | Aortic Neck Dilatation Is Different After F/EVAR And EVAR: What Is The Reason And Why Is It Important For Outcomes |
Presenter(s):Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAM RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts |
Presenter(s):Jan D. Blankensteijn, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | Do AAA Necks And Sacs Dilate After F/EVAR For Juxtarenal AAAs At 1 And 5 Years: What Are The Good Or Bad Consequences Of Neck And Sac Enlargement: What Can Be Done To Improve Results |
Presenter(s):Benjamin W. Starnes, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:36 PM - 1:41 PM | DEBATE: Not So: Ovation Stent-Grafts (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft |
Presenter(s):Mahmoud B. Malas, MD, MHS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:42 PM - 1:47 PM | Why We Need A New RCT Comparing EVAR With Watchful Surveillance In Women With Small AAAs |
Presenter(s):Janet T. Powell, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:48 PM - 1:53 PM | Causes And Treatment Of Ureter-To-Iliac Artery Fistula: When Open, When Endo Treatment And Results |
Presenter(s):Piotr M. Kasprzak, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:54 PM - 1:59 PM | Presenting Small AAAs As Ticking Time Bombs Or Unexploded Grenades Is Wrong-Headed And Harmful: Diameter-Based Indications For AAA Repair May Lead To Unnecessary Procedures |
Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Wednesday
SESSION 44:
MORE NEW DEVELOPMENTS IN AAAs: HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
|
|
x | |
AAA SAC THROMBUS LOAD | |
2:06 PM - 2:11 PM | Impact Of Thrombus In AAA Sac And Neck On AAA Behavior And EVAR Outcomes: How To Quantitate Thrombus Load And Distribution |
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:12 PM - 2:17 PM | DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And With Rupture: By What Mechanisms Is Thrombus Harmful And How Can Thrombus Load Be Quantitated |
Presenter(s):David H. Deaton, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:18 PM - 2:23 PM | DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
OTHER AAA RELATED TOPICS | |
2:24 PM - 2:29 PM | Graft Infolding: A Unique EVAR Complication: How To Prevent It And How To Treat It |
Presenter(s):Ashraf Mansour, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:30 PM - 2:35 PM | Perioperative Mortality With F/EVAR And B/EVAR Is Inversely Related To Hospital Volume For These Procedures: What About Surgeon Volume From A National Audit Database |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:36 PM - 2:41 PM | Favorable Anatomy For Endovascular Repair Is Preserved During Two Years Of Observation Of Small AAAs |
Presenter(s):Jon S. Matsumura, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:42 PM - 2:47 PM | 1-Year Sac Dynamics Predict Survival, Rupture And Need For Re-Intervention Long-Term After EVAR: Shrinkage Is Better Than Stable: Stable Is Better Than Expansion In Population Based Studies |
Presenter(s):Marc L. Schermerhorn, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:48 PM - 2:53 PM | Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries |
Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:54 PM - 2:59 PM | 4X Increased 18F FDG Uptake On PET CT In Female AAA Patients Compared To Males Indicates Increased Aortic Wall Inflammations: Does This Explain Increased Rupture Risk In Females: Implications For Treatment |
Presenter(s):Natzi Sakalihasan, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:00 PM - 3:06 PM | Panel Discussion |
3:06 PM - 3:15 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Wednesday
SESSION 45:
SHORT HOT AORTIC TOPICS (4 ¾-MINUTE FAST PACED TALKS
|
|
x | |
3:15 PM - 3:20 PM | Large Diameter AAA Necks (>34 mm) Negatively Impact Patient Survival After EVAR: Is Inflammation Involved: How Should Such Patients Be Treated |
Presenter(s):Matt M. Thompson, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:20 PM - 3:25 PM | A Large Proportion Of EVARs Are Performed On AAAs Smaller Than The SVS Guideline: What Is The Long-Term Effect And What Should Be Done About It |
Presenter(s):Sal Scali, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:25 PM - 3:30 PM | Late Delayed Renal Artery Revascularization After Inadvertent Occlusion For Many Days Is Worthwhile: Collaterals Keep The Kidney Viable Although No Urine Is Produced |
Presenter(s):Nikolaos Tsilimparis, MD; PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:30 PM - 3:35 PM | Giant Hypogastric Artery Aneurysms: Strategies And Techniques For Treating Them Endovascularly |
Presenter(s):Jacques Busquet, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:35 PM - 3:40 PM | Impact Of COVID, The NICE Guidelines And Changing Disease Patterns On AAA Practice In The UK |
Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:40 PM - 3:45 PM | TEVAR For Acute Complicated TBAD: Improved Outcomes When The Endograft Is Extended To Zone 2 Versus Zone 3: Why Is This So |
Presenter(s):Jean M. Panneton, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:45 PM - 3:50 PM | Long-Term Propensity Matched Comparison Of Open Repair And F/B/EVAR For Pararenal And Paravisceral AAAs |
Presenter(s):Giovanni Tinelli, MD, PhD / Yamume Tshomba, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:50 PM - 3:55 PM | Panel Discussion |
3:55 PM - 4:00 PM | Visceral Debranching With A Simple Aortic Endograft Is The Best Way To Treat TAAAs In Good Risk Patients: How To Do It Safely |
Presenter(s):Guillermo A. Escobar, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:00 PM - 4:05 PM | Shaggy Aortic Score: What Is It: How Is It Associated With Postoperative Lower Extremity Weakness After F/B/EVAR |
Presenter(s):Jade S. Hiramoto, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:05 PM - 4:10 PM | Laser In Situ F/EVAR As An Off-The-Shelf Option For Ruptured Complex Or Short Necked AAAs And Failed EVAR: Experience And Technical Tips |
Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:10 PM - 4:15 PM | Advantages And Disadvantages Of The BeGraft, BeGraft Plus (Bentley) And Advanta (iCAST™ – Getinge) Bridging Stents For F/B/EVAR: Experience With >2000 Target Vessels |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:15 PM - 4:20 PM | Update On Performing EVAR With Only IVUS Guidance To Decrease Radiation: Technical Tips And 4-Year Results |
Presenter(s):Jörg Tessarek, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:20 PM - 4:25 PM | Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation After EVAR With Self-Expanding Endografts: What Are The Differences In Neck Behavior After Excluder And Endurant Endografts |
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:25 PM - 4:35 PM | Panel Discussion |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Wednesday
SESSION 46:
MORE SHORT HOT NEW TOPICS RELATED TO AORTO-ILIAC AND CAROTID DISEASE AND THEIR TREATMENTS (4 ¾-MINUTE FAST PACED TALKS)
|
|
x | |
4:35 PM - 4:40 PM | Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Outcomes |
Presenter(s):Naoki Fujimura, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:40 PM - 4:45 PM | Endovascular Repair Of Thoracic Aneurysms With TEVAR Outside IFUs: Value And Limitations: From A Multicenter Study |
Presenter(s):Fabio Verzini, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:45 PM - 4:50 PM | How To Avoid ‘Lost To Follow Up’ After Invasive Treatment Of AAAs And Why Is It Important |
Presenter(s):Matthew W. Mell, MD, MS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:50 PM - 4:55 PM | The VORTEC Technique For Revascularizing Hypogastric Arteries Without Clamping Or Suturing: How Does It Work And Advantages |
Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG / Mario L. Lachat, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:55 PM - 5:00 PM | Impact Of Iliac Aneurysms On The Treatment Of Complex AAAs |
Presenter(s):Matthew J. Eagleton, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:00 PM - 5:05 PM | Isolated Iliac Artery AneurysmS Do NOT Need To Be Treated Until They Are At Least 4 Centimeters In Diameter |
Presenter(s):Christopher J. Smolock, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:05 PM - 5:10 PM | How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results |
Presenter(s):Luis A. Sanchez, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:10 PM - 5:15 PM Power Point Presentation with Synched Audio |
3-Stage Concept For Treating Mega-Aortic Syndrome: Frozen Elephant Trunk (FET), TEVAR, Distal Open Repair: Results |
Presenter(s):Martin Czerny, MD Location: Trianon Ballroom, 3rd Floor |
|
5:15 PM - 5:20 PM | Panel Discussion |
CAROTID RELATED TOPICS | |
5:20 PM - 5:25 PM | New Findings Regarding Carotid In-Stent Restenosis: What Is Its Rate Of Progression And Its Clinical Significance |
Presenter(s):Zach AbuRahma, DO / Ali F. AbuRahma, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:25 PM - 5:30 PM | Intracranial Angiography During TCAR: Technique And Value |
Presenter(s):Peter L. Faries, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:30 PM - 5:35 PM Power Point Presentation with Synched Audio |
Clinical Results Of A Micronet Covered Carotid-Stent (C-GUARD): Analysis Of 145 Patients At Two Sites: Advantages And Disadvantages |
Presenter(s):Christian Wissgott, MD / Christoph Kopetsch, MD / Reimer Andresen, MD Location: Trianon Ballroom, 3rd Floor |
|
MORE AORTA RELATED TOPICS | |
5:35 PM - 5:40 PM | Improved Survival After Implementation Of A Large Scale Dedicated Network For Aortic Emergencies: Why The SOS Aorta System Works |
Presenter(s):Jean-Marc Alsac, MD, PhD |
|
View Slides in PDF | |
5:40 PM - 5:45 PM | Physician Modified Gore C3 Excluder Endograft For TAAA Repair |
Presenter(s):Wayne W. Zhang, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:45 PM - 5:50 PM | The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It |
Presenter(s):Sukgu Han, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:50 PM - 5:55 PM | Role Of Endovascular And Open Treatment For Mid Aortic Syndrome In Children, Teenagers And Young Adults |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:55 PM - 6:00 PM | Supra-Aortic Trunk Revascularization Of Any Sort With TEVAR Increases Stroke Risk |
Presenter(s):Mark K. Eskandari, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
6:00 PM - 6:05 PM | An Unrecognized Mechanism For Causing Aortic Dissections: Shock Wave Energy Rather Than Increased Arterial Pressure Causes The Tear: How Does It Work And How To Decrease The Risk |
Presenter(s):Erno Remsey-Semmelweis, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
6:05 PM - 6:10 PM | Panel Discussion |
6:10 PM - 6:10 PM | End of Program F |
END OF SESSION 46 |